Physician Wealth Advisors’s Freeport-McMoran FCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$67.7K Buy
1,077
+131
+14% +$8.42K 0.01% 380
2026
Q1
$55.6K Buy
946
+22
+2% +$1.33K 0.01% 379
2025
Q4
$46.9K Buy
924
+176
+24% +$7.63K 0.01% 404
2025
Q3
$29.3K Buy
748
+46
+7% +$2K ﹤0.01% 488
2025
Q2
$30.4K Buy
702
+162
+30% +$6.15K ﹤0.01% 433
2025
Q1
$20.4K Sell
540
-195
-27% -$7.46K ﹤0.01% 482
2024
Q4
$28K Buy
+735
New +$32.9K ﹤0.01% 446

Other funds holding FCX

Physician Wealth Advisors's FCX Position: Q2 2026 in Review

Physician Wealth Advisors increased its Freeport-McMoran (FCX) stake by 14% in Q2 2026, buying an estimated $8.42K and bringing the position to 1,077 shares worth $67.7K. The position accounts for 0.01% of the portfolio, ranked #380.

Physician Wealth Advisors first reported a position in FCX in Q4 2024 and has held it in 7 quarters since. 382 funds tracked by Wall St. Rank hold FCX as of Q2 2026.

  • Physician Wealth Advisors held 1,077 shares of Freeport-McMoran worth $67.7K as of Q2 2026.
  • Physician Wealth Advisors bought 131 Freeport-McMoran shares in Q2 2026, an estimated $8.42K.
  • Freeport-McMoran made up 0.01% of Physician Wealth Advisors's portfolio in Q2 2026, its #380 holding.
  • Physician Wealth Advisors first reported a position in Freeport-McMoran in Q4 2024 and has held it in 7 quarters since.
  • 382 funds tracked by Wall St. Rank held Freeport-McMoran as of Q2 2026.

Based on Physician Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.